Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes

Abstract

Leflunomide, alone or in combination, has potential utility in treatment of complex CMV syndromes and in long-term suppression of viremia. The optimal duration of therapy and the balance of risks and benefits are not yet known.